283 related articles for article (PubMed ID: 33919295)
1. Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia.
Bastida JM; Gonzalez-Porras JR; Rivera J; Lozano ML
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919295
[TBL] [Abstract][Full Text] [Related]
2. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
Elife; 2021 Jun; 10():. PubMed ID: 34059198
[TBL] [Abstract][Full Text] [Related]
3. The role of an accurate diagnosis of inherited thrombocytopenia as the basis for an effective treatment. A case of MYH9 syndrome treated with a TPO-RA.
Porrazzo M; Baldacci E; Ferretti A; Miulli E; Chistolini A; Pecci A; Mazzucconi MG; Foà R; Santoro C
Haemophilia; 2019 Jul; 25(4):e288-e290. PubMed ID: 30993846
[No Abstract] [Full Text] [Related]
4. Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.
Pecci A
Int J Hematol; 2013 Jul; 98(1):34-47. PubMed ID: 23636669
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
Bento L; Bastida JM; García-Cadenas I; García-Torres E; Rivera D; Bosch-Vilaseca A; De Miguel C; Martínez-Muñoz ME; Fernández-Avilés F; Roldán E; Chinea A; Yáñez L; Zudaire T; Vaz CP; Espigado I; López J; Valcárcel D; Duarte R; Cabrera R; Herrera C; González-Porras JR; Gutiérrez A; Solano C; Sampol A;
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1825-1831. PubMed ID: 31152794
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin-receptor agonists.
Basciano PA; Bussel JB
Curr Opin Hematol; 2012 Sep; 19(5):392-8. PubMed ID: 22872157
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of
Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
[No Abstract] [Full Text] [Related]
9. Analyses of Genetic and Clinical Parameters for Screening Patients With Inherited Thrombocytopenia with Small or Normal-Sized Platelets.
Ouchi-Uchiyama M; Sasahara Y; Kikuchi A; Goi K; Nakane T; Ikeno M; Noguchi Y; Uike N; Miyajima Y; Matsubara K; Koh K; Sugita K; Imaizumi M; Kure S
Pediatr Blood Cancer; 2015 Dec; 62(12):2082-8. PubMed ID: 26175287
[TBL] [Abstract][Full Text] [Related]
10. Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists.
Garabet L; Ghanima W; Hellum M; Sandset PM; Bussel JB; Tran H; Henriksson CE
Platelets; 2020; 31(3):322-328. PubMed ID: 31280643
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
Makar RS; Zhukov OS; Sahud MA; Kuter DJ
Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.
Gudbrandsdottir S; Frederiksen H; Hasselbalch H
Platelets; 2012; 23(6):423-9. PubMed ID: 22185370
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
[TBL] [Abstract][Full Text] [Related]
14. Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice.
Iino M; Sakamoto Y; Sato T
Int J Hematol; 2020 Aug; 112(2):159-168. PubMed ID: 32476083
[TBL] [Abstract][Full Text] [Related]
15. Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer.
Paciullo F; Bury L; Gresele P
Int J Hematol; 2020 Nov; 112(5):725-727. PubMed ID: 32557126
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin in thrombocytopenias of childhood.
Dame C
Semin Thromb Hemost; 2001 Jun; 27(3):215-28. PubMed ID: 11446655
[TBL] [Abstract][Full Text] [Related]
17. Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults.
Červinek L; Mayer J; Doubek M
Int J Hematol; 2015 Jul; 102(1):7-11. PubMed ID: 25833724
[TBL] [Abstract][Full Text] [Related]
18. Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation.
Mahat U; Rotz SJ; Hanna R
Biol Blood Marrow Transplant; 2020 Mar; 26(3):e65-e73. PubMed ID: 31830528
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review.
Birocchi S; Podda GM; Manzoni M; Casazza G; Cattaneo M
Platelets; 2021 Feb; 32(2):216-226. PubMed ID: 32281449
[TBL] [Abstract][Full Text] [Related]
20. Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related Thrombocytopenia and MYH9-related diseases.
Balduini A; Raslova H; Di Buduo CA; Donada A; Ballmaier M; Germeshausen M; Balduini CL
Eur J Med Genet; 2018 Nov; 61(11):715-722. PubMed ID: 29545013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
